Tate & Lyle
Tate & Lyle PLC is a multinational company headquartered in London, specializing in providing high-quality ingredients and solutions for the food, beverage, and other industries worldwide. The company operates through three main segments: Food & Beverage Solutions, Sucralose, and Primary Products. Its offerings include texturants, nutritive sweeteners like high fructose corn syrup and dextrose, health and wellness ingredients, and stabilizers. Additionally, Tate & Lyle supplies industrial starches for various applications, including paper and packaging, as well as acidulants and commodities for animal nutrition. Following the divestiture of its commodity ingredients business in 2022 and its previous exit from the sugar sector, the company has shifted its focus towards specialty ingredients such as sweeteners, starches, and soluble fiber. With a workforce of approximately 2,700 employees, Tate & Lyle operates in over 140 countries, generating a significant portion of its revenue from North America.
Top Stages
25 past transactions
Quantum Hi-Tech China Biological
Acquisition in 2022
Quantum Hi-Tech (China) Biological Co., Ltd., founded in 2000 and headquartered in Guangzhou, China, specializes in microecological nutrition and healthcare. The company offers a range of services, including medical contract research and contract development and manufacturing for pre-clinical stages. In addition, it engages in the research, production, and sales of prebiotic fibers, which serve as microecological fortification ingredients, original design manufacturing products, and specialized medical foods. The company, formerly known as Quantum Hi-Tech (China) Biological Co., Ltd., adopted its current name in September 2020, reflecting its focus on advancing health and nutrition through innovative solutions.
Sweet Green Fields
Acquisition in 2020
Sweet Green Fields is a prominent innovator in the development of stevia leaf extracts, focusing on natural sweeteners and food additives for the beverages, dairy, and snacks industries. Established in 1999, the company began with a comprehensive plant breeding program aimed at creating improved stevia varieties. This initiative has led to proprietary stevia leaf advancements that support its commitment to delivering exceptional taste through its "taste the extraordinary" program. By integrating food science with its stevia innovations, Sweet Green Fields offers a diverse portfolio of sugar-like tasting sweeteners that cater to various consumer needs and preferences. As of December 2020, Sweet Green Fields operates as a subsidiary of Tate & Lyle plc.
Chaodee Modified Starch
Acquisition in 2020
Chaodee Modified Starch is a prominent manufacturer of tapioca-modified food starch based in Nakhon Ratchasima, Thailand. The company specializes in producing gluten-free and non-GMO modified tapioca and cassava starch, catering to a range of food applications. Its products are utilized in various culinary items, including sauces, instant and canned soups, dressings, yogurt, and puddings. Chaodee Modified Starch is recognized for providing high-quality, versatile food alternatives that meet the growing demand for healthier ingredients in the food industry.
Changing Health
Seed Round in 2018
Changing Health Limited, established in Newcastle upon Tyne, UK in 2015, specializes in developing a digital behavior change platform focused on supporting lifestyle modifications and chronic disease management, particularly type 2 diabetes. The company's core offering is an evidence-based program that combines health coaching rooted in behavioral psychology with engaging digital education, empowering users to make lasting changes in nutrition and exercise habits. This approach enables healthcare organizations worldwide to deliver effective support at scale, optimizing limited resources.
Prolupin
Venture Round in 2018
Prolupin GmbH is a German company founded in 2010, specializing in the development and production of plant-based food ingredients derived from lupine seeds. Based in Grimmen, Prolupin offers a range of products tailored for various sectors of the food industry, including bakery, meat, pasta, and health foods. The company's portfolio includes lupine ingredients, ice cream products, and protein isolates, emphasizing vegan and gluten-free options. As a spin-off from the Fraunhofer Institute for Process Engineering and Packaging, Prolupin benefits from advanced expertise in lupine fractionation and food technology, reinforced by several patents held by the institute. This positions the company strongly within the growing market for vegetable proteins, catering to the increasing demand for cholesterol and lactose-free alternatives.
Evolve Biosystems
Series B in 2017
Evolve Biosystems, Inc. is a life sciences company based in Davis, California, that focuses on developing probiotic-based biotherapeutics aimed at establishing, restoring, and maintaining a healthy human microbiome. Incorporated in 2011, the company utilizes a discovery platform that addresses dysbiosis issues throughout the human life cycle and in production animals. Evolve Biosystems specializes in probiotic bacteria activated with specific prebiotic oligosaccharides and employs various delivery systems to support gut health, particularly in infants during their first six months of life. Their product offerings include consumer-directed solutions for home use as well as specialized products for neonatal intensive care units, addressing unmet clinical needs in both human and animal health.
Nutriati
Series A in 2017
Nutriati is a company based in Henrico, Virginia, founded in 2013 that specializes in the research, development, production, and commercialization of plant-based food products. The company produces gluten-free chickpea protein and chickpea flour, which are designed to meet consumer demand for high-protein and non-allergenic foods. These functional ingredients are used in a variety of applications including bread, baked goods, pasta, sauces, snacks, and plant-based meat alternatives. Nutriati's products cater to the clean taste profile and functional performance demanded by consumer packaged goods companies.
Evolve Biosystems
Series A in 2015
Evolve Biosystems, Inc. is a life sciences company based in Davis, California, that focuses on developing probiotic-based biotherapeutics aimed at establishing, restoring, and maintaining a healthy human microbiome. Incorporated in 2011, the company utilizes a discovery platform that addresses dysbiosis issues throughout the human life cycle and in production animals. Evolve Biosystems specializes in probiotic bacteria activated with specific prebiotic oligosaccharides and employs various delivery systems to support gut health, particularly in infants during their first six months of life. Their product offerings include consumer-directed solutions for home use as well as specialized products for neonatal intensive care units, addressing unmet clinical needs in both human and animal health.
Gemacom Tech Indústria e Comércio
Acquisition in 2014
Gemacom Tech Indústria e Comércio SA is a manufacturer and supplier specializing in food ingredient solutions. The company develops and produces a wide range of products, including modified starches, aromas, colorants, and various stabilizing mixtures. Their offerings encompass milk and whey protein concentrates, sweeteners, thickeners, and stabilizers, as well as fruit and jam preparations, toppings, and fillings. Additionally, Gemacom Tech provides automatized powder mixtures, cheese pastes, and condiments, catering to the diverse needs of the food industry.
Winway Biotechnology Natong
Acquisition in 2014
Winway Biotechnology Natong Co. Ltd. manufactures and markets polydextrose specialty fiber. The company is based in Nantong, China.
Jiangsu Howbetter Food
Acquisition in 2013
Jiangsu Howbetter Food Co. Ltd. provides stabilizer systems and ingredient blends for the dairy and beverage industries.
Biovelop International
Acquisition in 2013
Biovelop International AB is a developer and manufacturer of oat beta glucan and specialty ingredients derived from cereal grains. The company specializes in the fractionation of oats to create high-quality ingredients for various applications, including food, beverages, nutritional supplements, cosmetics, and personal care products. Notable products include PromOat, a soluble fiber derived from oat bran that aids in lowering cholesterol, modulating blood sugar levels, and enhancing digestive health, and Avenacare, a liquid form of oat beta glucan designed for cosmetic use to alleviate skin irritation and strengthen hair. Additionally, Biovelop produces prOATein, a non-dairy, non-GMO oat protein alternative suitable for boosting the protein content in a range of nutritious products such as bars, baked goods, meal replacement shakes, and sports nutrition items.
Allylix
Venture Round in 2012
Allylix, Inc. is an early-stage biotechnology company specializing in the development of terpene products and their derivatives. Founded in 2002 and headquartered in San Diego, California, with research and development laboratories in Lexington, Kentucky, the company focuses on applications across various markets, including flavor and fragrance, food ingredients, pharmaceuticals, agriculture, and biofuels. Among its notable products is nootkatone, a grapefruit flavor utilized in fruit juices and citrus-flavored sodas. Allylix also develops sesquiterpenes for the aroma chemical segment of the flavor and fragrance market, as well as production platforms aimed at pharmaceutical, nutraceutical, and agricultural applications.
Allylix
Series C in 2010
Allylix, Inc. is an early-stage biotechnology company specializing in the development of terpene products and their derivatives. Founded in 2002 and headquartered in San Diego, California, with research and development laboratories in Lexington, Kentucky, the company focuses on applications across various markets, including flavor and fragrance, food ingredients, pharmaceuticals, agriculture, and biofuels. Among its notable products is nootkatone, a grapefruit flavor utilized in fruit juices and citrus-flavored sodas. Allylix also develops sesquiterpenes for the aroma chemical segment of the flavor and fragrance market, as well as production platforms aimed at pharmaceutical, nutraceutical, and agricultural applications.
Aquapharm Biodiscovery
Series C in 2010
Aquapharm is an innovative drug discovery company focussed on developing new products founded on the chemical diversity of marine micro-organisms. Their core focus is the development of novel pharmaceutical compounds leading to the development of novel antibiotics, targeting both Gram negative and Gram positive infections. In addition, Aquapharm's development pipeline is also fed by an active discovery portfolio of anti-oxidants, anti-inflammatories and novel biocatalysts.
Allylix
Series C in 2010
Allylix, Inc. is an early-stage biotechnology company specializing in the development of terpene products and their derivatives. Founded in 2002 and headquartered in San Diego, California, with research and development laboratories in Lexington, Kentucky, the company focuses on applications across various markets, including flavor and fragrance, food ingredients, pharmaceuticals, agriculture, and biofuels. Among its notable products is nootkatone, a grapefruit flavor utilized in fruit juices and citrus-flavored sodas. Allylix also develops sesquiterpenes for the aroma chemical segment of the flavor and fragrance market, as well as production platforms aimed at pharmaceutical, nutraceutical, and agricultural applications.
Fugeia
Venture Round in 2008
Fugeia NV specializes in developing ingredients and nutrition technologies, focusing on arabinoxylan-oligosaccharides (AXOS), which offer various health benefits associated with wholegrain wheat. These benefits include potential prevention of lifestyle diseases such as diabetes, obesity, cardiovascular conditions, and cancer. The company has innovated technologies for prebiotic bread and AXOS-enriched beer, enhancing the levels of these beneficial compounds in these products. Fugeia's offerings cater to a wide range of market segments, including dairy and non-dairy beverages, ready-to-eat cereals, cookies, biscuits, bread, and pastries, as well as dietary supplements and therapeutics. Founded in 2008, the company is based in Heverlee, Belgium.
Allylix
Venture Round in 2007
Allylix, Inc. is an early-stage biotechnology company specializing in the development of terpene products and their derivatives. Founded in 2002 and headquartered in San Diego, California, with research and development laboratories in Lexington, Kentucky, the company focuses on applications across various markets, including flavor and fragrance, food ingredients, pharmaceuticals, agriculture, and biofuels. Among its notable products is nootkatone, a grapefruit flavor utilized in fruit juices and citrus-flavored sodas. Allylix also develops sesquiterpenes for the aroma chemical segment of the flavor and fragrance market, as well as production platforms aimed at pharmaceutical, nutraceutical, and agricultural applications.
Aquapharm Biodiscovery
Series B in 2007
Aquapharm is an innovative drug discovery company focussed on developing new products founded on the chemical diversity of marine micro-organisms. Their core focus is the development of novel pharmaceutical compounds leading to the development of novel antibiotics, targeting both Gram negative and Gram positive infections. In addition, Aquapharm's development pipeline is also fed by an active discovery portfolio of anti-oxidants, anti-inflammatories and novel biocatalysts.
G. C. Hahn
Acquisition in 2007
G. C. Hahn & Co. manufactures customized food stabilizer systems for the food industry. G. C. Hahn & Co. products are used in milk, delicatessen, ready meals, sauces and soups, bakery, meat products, beverages, filling aids, fish products, savory snacks, fruit products, food service, and ice cream applications.
Cesalpinia food SpA
Acquisition in 2005
Cesalpinia food SpA manufactues and supplies food additives for food, pharmaceutical, and pet food industries. Cesalpinia food SpA provides gums, thickeners, stabilizers, jellifying agents, blends, and natural flours.
Continental Custom Ingredients
Acquisition in 2005
CCI is a recognised leader in dairy stabilisers and emulsifier systems and works closely with customers to develop ingredient systems for the North American market. CCI also has expertise in beverage flavours and vitamin and mineral fortification.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.